Insight

What is the next big innovation coming to the Life Sciences sector?

October 16th 2024
In our recent Life Sciences round table, Compass Carter Osborne welcomed a cohort of industry leaders to discuss where the next big innovation in the Life Sciences sector is coming from.

Addressing a broad range of topics, panelists addressed questions on biotech funding bounce-back; investment appetite in innovative technologies; quantum computing and AI; driving positive outcomes for the sector; and much more.

Key areas of discussion covered off:

  • Which innovations might have the biggest positive impact on the sector in the next five years
  • Investor standpoint: which technologies are you most likely to invest in, and why?
  • Quantum Computing – hype or hope?
  • What can the Life Sciences sector do to ensure the potential for innovation through computing is delivered?
  • Biotech funding cycle bounce-back
  • Therapeutic or devices in 2025 – target markets
 
The CCO team extend their sincere thanks to the following participants:
  • Geoff Dobson (Discussion Chair)
  • Matthew Fyfe, Storm Therapeutics
  • Prashant Shah, O2h Discovery
  • Dr Iris Good, Plural
  • Jerry Wu, TusPark Holdings
  • Aline Charpentier, Bruntwood SciTech
  • Sebastian Stachowiak, ICE Biopharma
  • Colin Sims, Adthera Bio
  • Dr Suhail Nurbhai, Mission Therapeutics
  • Usman “Oz” Azam, Inspirna
  • Stephen Dowd, Confo Therapeutics
  • Tarquin Bennett-Coles, Compass Carter Osborne
  • Martin Anderson, Carrot Recruitment
  • Alex Boulger, Compass Carter Osborne
To obtain a copy of the full report and the responses to each question, download your copy below.

Tarquin Bennett-Coles, Director Compass Carter Osborne

Tarquin Bennett-Coles BEd (Hons)

Director

020 8036 3530
Geoff Dobson, Non-Executive Advisor Compass Carter Osborne

Geoff Dobson cFCIPD

Non-Executive Advisor

0208 036 3530